mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |